Drug · DIN 02256487
VFEND
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 12, 2004; first marketed November 12, 2004.
- Drug Identification Number (DIN)
- 02256487
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Voriconazole J02AC03
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VORICONAZOLE | 200 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 20, 2004: NOC 4915New Drug Submission (NDS)
Other DINs named VFEND
- DIN 02256460 · Marketed
- DIN 02256479 · Marketed
- DIN 02279991 · Marketed